nodes	percent_of_prediction	percent_of_DWPC	metapath
Hydrocortamate—Methyltestosterone—Ethinyl Estradiol—osteoporosis	0.278	0.523	CrCrCtD
Hydrocortamate—Testosterone—Estradiol—osteoporosis	0.254	0.477	CrCrCtD
Hydrocortamate—CYP3A4—Estropipate—osteoporosis	0.0829	0.181	CbGbCtD
Hydrocortamate—CYP3A4—Calcitriol—osteoporosis	0.0829	0.181	CbGbCtD
Hydrocortamate—CYP3A4—Ergocalciferol—osteoporosis	0.0662	0.145	CbGbCtD
Hydrocortamate—CYP3A4—Raloxifene—osteoporosis	0.0553	0.121	CbGbCtD
Hydrocortamate—CYP3A4—Ethinyl Estradiol—osteoporosis	0.0534	0.117	CbGbCtD
Hydrocortamate—CYP3A4—Cholecalciferol—osteoporosis	0.0427	0.0934	CbGbCtD
Hydrocortamate—CYP3A4—Conjugated Estrogens—osteoporosis	0.0392	0.0858	CbGbCtD
Hydrocortamate—CYP3A4—Estradiol—osteoporosis	0.0344	0.0753	CbGbCtD
Hydrocortamate—Fluoxymesterone—SHBG—osteoporosis	0.000954	0.13	CrCbGaD
Hydrocortamate—Spironolactone—SHBG—osteoporosis	0.000873	0.119	CrCbGaD
Hydrocortamate—Medroxyprogesterone Acetate—SHBG—osteoporosis	0.000818	0.112	CrCbGaD
Hydrocortamate—Methyltestosterone—SHBG—osteoporosis	0.00077	0.105	CrCbGaD
Hydrocortamate—Fluoxymesterone—ESR1—osteoporosis	0.000644	0.088	CrCbGaD
Hydrocortamate—Hydrocortisone—SHBG—osteoporosis	0.00058	0.0792	CrCbGaD
Hydrocortamate—Methyltestosterone—CYP19A1—osteoporosis	0.000565	0.0772	CrCbGaD
Hydrocortamate—Medroxyprogesterone Acetate—ESR1—osteoporosis	0.000553	0.0755	CrCbGaD
Hydrocortamate—Progesterone—SHBG—osteoporosis	0.000473	0.0645	CrCbGaD
Hydrocortamate—Testosterone—SHBG—osteoporosis	0.000447	0.061	CrCbGaD
Hydrocortamate—CYP3A4—Drug Induction of Bile Acid Pathway—SLC51A—osteoporosis	0.000347	0.0931	CbGpPWpGaD
Hydrocortamate—Testosterone—CYP19A1—osteoporosis	0.000328	0.0448	CrCbGaD
Hydrocortamate—Progesterone—ESR1—osteoporosis	0.000319	0.0436	CrCbGaD
Hydrocortamate—NR3C1—Serotonin Receptor 4/6/7 and NR3C Signaling—RAP1A—osteoporosis	0.000271	0.0728	CbGpPWpGaD
Hydrocortamate—NR3C1—Signaling events mediated by HDAC Class II—TUBA1B—osteoporosis	0.000269	0.0722	CbGpPWpGaD
Hydrocortamate—NR3C1—Transcription factor regulation in adipogenesis—IRS2—osteoporosis	0.000111	0.0299	CbGpPWpGaD
Hydrocortamate—NR3C1—Nuclear Receptors—ESR2—osteoporosis	0.000111	0.0298	CbGpPWpGaD
Hydrocortamate—NR3C1—Transcription factor regulation in adipogenesis—LEP—osteoporosis	0.000109	0.0293	CbGpPWpGaD
Hydrocortamate—NR3C1—AP-1 transcription factor network—COL1A2—osteoporosis	9.8e-05	0.0263	CbGpPWpGaD
Hydrocortamate—NR3C1—Transcription factor regulation in adipogenesis—IRS1—osteoporosis	9.72e-05	0.0261	CbGpPWpGaD
Hydrocortamate—NR3C1—Endoderm Differentiation—DKK1—osteoporosis	9.46e-05	0.0254	CbGpPWpGaD
Hydrocortamate—NR3C1—AP-1 transcription factor network—NFATC1—osteoporosis	9.32e-05	0.025	CbGpPWpGaD
Hydrocortamate—NR3C1—Nuclear Receptors—VDR—osteoporosis	8.79e-05	0.0236	CbGpPWpGaD
Hydrocortamate—NR3C1—Nuclear Receptor transcription pathway—ESR2—osteoporosis	8.76e-05	0.0235	CbGpPWpGaD
Hydrocortamate—NR3C1—Regulation of nuclear SMAD2/3 signaling—COL1A2—osteoporosis	8.72e-05	0.0234	CbGpPWpGaD
Hydrocortamate—NR3C1—Endoderm Differentiation—PTHLH—osteoporosis	8.24e-05	0.0221	CbGpPWpGaD
Hydrocortamate—NR3C1—Glucocorticoid receptor regulatory network—NFATC1—osteoporosis	8.21e-05	0.0221	CbGpPWpGaD
Hydrocortamate—NR3C1—Glucocorticoid receptor regulatory network—BGLAP—osteoporosis	7.48e-05	0.0201	CbGpPWpGaD
Hydrocortamate—NR3C1—Nuclear Receptor transcription pathway—VDR—osteoporosis	6.95e-05	0.0187	CbGpPWpGaD
Hydrocortamate—NR3C1—Signaling events mediated by HDAC Class II—ESR1—osteoporosis	6.72e-05	0.0181	CbGpPWpGaD
Hydrocortamate—NR3C1—Nuclear Receptors—ESR1—osteoporosis	6.72e-05	0.0181	CbGpPWpGaD
Hydrocortamate—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—osteoporosis	5.54e-05	0.0149	CbGpPWpGaD
Hydrocortamate—NR3C1—Adipogenesis—WNT1—osteoporosis	5.43e-05	0.0146	CbGpPWpGaD
Hydrocortamate—NR3C1—Nuclear Receptor transcription pathway—ESR1—osteoporosis	5.31e-05	0.0143	CbGpPWpGaD
Hydrocortamate—NR3C1—SIDS Susceptibility Pathways—GAPDH—osteoporosis	5.16e-05	0.0139	CbGpPWpGaD
Hydrocortamate—NR3C1—Transcription factor regulation in adipogenesis—TNF—osteoporosis	5.04e-05	0.0135	CbGpPWpGaD
Hydrocortamate—NR3C1—Adipogenesis—BMP2—osteoporosis	4.91e-05	0.0132	CbGpPWpGaD
Hydrocortamate—NR3C1—Regulation of nuclear SMAD2/3 signaling—VDR—osteoporosis	4.8e-05	0.0129	CbGpPWpGaD
Hydrocortamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—osteoporosis	4.4e-05	0.0118	CbGpPWpGaD
Hydrocortamate—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—osteoporosis	4.34e-05	0.0117	CbGpPWpGaD
Hydrocortamate—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—osteoporosis	4.14e-05	0.0111	CbGpPWpGaD
Hydrocortamate—NR3C1—AP-1 transcription factor network—ESR1—osteoporosis	4.12e-05	0.0111	CbGpPWpGaD
Hydrocortamate—NR3C1—Transcription factor regulation in adipogenesis—IL6—osteoporosis	4.07e-05	0.0109	CbGpPWpGaD
Hydrocortamate—NR3C1—Regulation of nuclear SMAD2/3 signaling—ESR1—osteoporosis	3.67e-05	0.00985	CbGpPWpGaD
Hydrocortamate—NR3C1—SIDS Susceptibility Pathways—ESR2—osteoporosis	3.58e-05	0.00962	CbGpPWpGaD
Hydrocortamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—osteoporosis	3.57e-05	0.00958	CbGpPWpGaD
Hydrocortamate—NR3C1—Glucocorticoid receptor regulatory network—POMC—osteoporosis	3.27e-05	0.00878	CbGpPWpGaD
Hydrocortamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—osteoporosis	3.18e-05	0.00855	CbGpPWpGaD
Hydrocortamate—CYP3A4—Tryptophan metabolism—CYP19A1—osteoporosis	2.86e-05	0.00768	CbGpPWpGaD
Hydrocortamate—NR3C1—Adipogenesis—IRS2—osteoporosis	2.69e-05	0.00722	CbGpPWpGaD
Hydrocortamate—NR3C1—Adipogenesis—LEP—osteoporosis	2.63e-05	0.00707	CbGpPWpGaD
Hydrocortamate—NR3C1—Adipogenesis—IRS1—osteoporosis	2.35e-05	0.00631	CbGpPWpGaD
Hydrocortamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP19A1—osteoporosis	2.31e-05	0.00621	CbGpPWpGaD
Hydrocortamate—CYP3A4—Oxidation by Cytochrome P450—CYP19A1—osteoporosis	2.28e-05	0.00613	CbGpPWpGaD
Hydrocortamate—NR3C1—Endoderm Differentiation—TGFB1—osteoporosis	2.19e-05	0.00588	CbGpPWpGaD
Hydrocortamate—NR3C1—Adipogenesis—IGF1—osteoporosis	2.17e-05	0.00584	CbGpPWpGaD
Hydrocortamate—NR3C1—AP-1 transcription factor network—MYC—osteoporosis	2.14e-05	0.00576	CbGpPWpGaD
Hydrocortamate—NR3C1—AP-1 transcription factor network—TGFB1—osteoporosis	2.14e-05	0.00575	CbGpPWpGaD
Hydrocortamate—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—osteoporosis	1.91e-05	0.00512	CbGpPWpGaD
Hydrocortamate—NR3C1—SIDS Susceptibility Pathways—IL6R—osteoporosis	1.91e-05	0.00512	CbGpPWpGaD
Hydrocortamate—NR3C1—Gene Expression—U2AF1—osteoporosis	1.9e-05	0.0051	CbGpPWpGaD
Hydrocortamate—CYP3A4—Biological oxidations—CYP27A1—osteoporosis	1.89e-05	0.00509	CbGpPWpGaD
Hydrocortamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP19A1—osteoporosis	1.87e-05	0.00503	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metapathway biotransformation—CYP27A1—osteoporosis	1.87e-05	0.00502	CbGpPWpGaD
Hydrocortamate—NR3C1—AP-1 transcription factor network—IL6—osteoporosis	1.61e-05	0.00433	CbGpPWpGaD
Hydrocortamate—NR3C1—Generic Transcription Pathway—ESR2—osteoporosis	1.51e-05	0.00406	CbGpPWpGaD
Hydrocortamate—NR3C1—SIDS Susceptibility Pathways—IL1B—osteoporosis	1.45e-05	0.00389	CbGpPWpGaD
Hydrocortamate—NR3C1—Glucocorticoid receptor regulatory network—IL6—osteoporosis	1.42e-05	0.00381	CbGpPWpGaD
Hydrocortamate—NR3C1—Gene Expression—RPL24—osteoporosis	1.41e-05	0.00379	CbGpPWpGaD
Hydrocortamate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—osteoporosis	1.39e-05	0.00373	CbGpPWpGaD
Hydrocortamate—NR3C1—Adipogenesis—TGFB1—osteoporosis	1.3e-05	0.0035	CbGpPWpGaD
Hydrocortamate—NR3C1—Adipogenesis—TNF—osteoporosis	1.22e-05	0.00327	CbGpPWpGaD
Hydrocortamate—NR3C1—Generic Transcription Pathway—VDR—osteoporosis	1.2e-05	0.00322	CbGpPWpGaD
Hydrocortamate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—osteoporosis	1.13e-05	0.00302	CbGpPWpGaD
Hydrocortamate—NR3C1—SIDS Susceptibility Pathways—TNF—osteoporosis	1.05e-05	0.00283	CbGpPWpGaD
Hydrocortamate—CYP3A4—Biological oxidations—CYP19A1—osteoporosis	9.95e-06	0.00267	CbGpPWpGaD
Hydrocortamate—NR3C1—Adipogenesis—IL6—osteoporosis	9.82e-06	0.00264	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metapathway biotransformation—CYP19A1—osteoporosis	9.81e-06	0.00264	CbGpPWpGaD
Hydrocortamate—NR3C1—Generic Transcription Pathway—ESR1—osteoporosis	9.17e-06	0.00246	CbGpPWpGaD
Hydrocortamate—NR3C1—SIDS Susceptibility Pathways—IL6—osteoporosis	8.49e-06	0.00228	CbGpPWpGaD
Hydrocortamate—NR3C1—Gene Expression—PSMA2—osteoporosis	8.15e-06	0.00219	CbGpPWpGaD
Hydrocortamate—NR3C1—Gene Expression—PSMA5—osteoporosis	8.15e-06	0.00219	CbGpPWpGaD
Hydrocortamate—NR3C1—Gene Expression—ESR2—osteoporosis	7.28e-06	0.00196	CbGpPWpGaD
Hydrocortamate—CYP3A4—Biological oxidations—POMC—osteoporosis	5.98e-06	0.00161	CbGpPWpGaD
Hydrocortamate—NR3C1—Gene Expression—VDR—osteoporosis	5.78e-06	0.00155	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—PKM—osteoporosis	5.64e-06	0.00152	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—FDPS—osteoporosis	5.64e-06	0.00152	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—PGLS—osteoporosis	5.35e-06	0.00144	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—GPD2—osteoporosis	5.35e-06	0.00144	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—PNP—osteoporosis	4.89e-06	0.00131	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—ATIC—osteoporosis	4.89e-06	0.00131	CbGpPWpGaD
Hydrocortamate—NR3C1—Generic Transcription Pathway—MYC—osteoporosis	4.77e-06	0.00128	CbGpPWpGaD
Hydrocortamate—NR3C1—Gene Expression—ESR1—osteoporosis	4.42e-06	0.00119	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—CA2—osteoporosis	4.16e-06	0.00112	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—OXCT1—osteoporosis	4.16e-06	0.00112	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—MGLL—osteoporosis	4.05e-06	0.00109	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—IDH2—osteoporosis	3.45e-06	0.000926	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—CYP27A1—osteoporosis	3.24e-06	0.00087	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—ACP5—osteoporosis	3.15e-06	0.000846	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—TPI1—osteoporosis	2.93e-06	0.000787	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—P4HB—osteoporosis	2.75e-06	0.00074	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—GAPDH—osteoporosis	2.7e-06	0.000726	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—RAP1A—osteoporosis	2.63e-06	0.000707	CbGpPWpGaD
Hydrocortamate—NR3C1—Gene Expression—MYC—osteoporosis	2.3e-06	0.000617	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—ENO1—osteoporosis	2.13e-06	0.000572	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—PSMA2—osteoporosis	2.1e-06	0.000563	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—PSMA5—osteoporosis	2.1e-06	0.000563	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—CYP19A1—osteoporosis	1.7e-06	0.000457	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—ADCY5—osteoporosis	1.39e-06	0.000373	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—GPX1—osteoporosis	1.39e-06	0.000372	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—MTHFR—osteoporosis	1.28e-06	0.000343	CbGpPWpGaD
Hydrocortamate—CYP3A4—Metabolism—POMC—osteoporosis	1.02e-06	0.000275	CbGpPWpGaD
